Browsing Tag
Thierry Bernard
5 posts
QIAGEN changed CEO while its board is reviewing strategic options. What does Jonathan Pratt inherit?
Jonathan Pratt has taken over as QIAGEN CEO after leading Filtration Group through its sale to Parker-Hannifin, inheriting a life-sciences company with a 29.4% adjusted operating margin, $301 million of first-half operating cash flow and an unresolved board-led strategic review.
Qiagen (NYSE: QGEN) at a crossroads ahead of new CEO and Q1 2026 results
Qiagen (NYSE: QGEN) retail investor roadmap: strategic review, CEO search, 2026 product pipeline and what the May earnings call means for shareholders.
Thermo Fisher scraps $11.5bn Qiagen deal after failed tender offer
Thermo Fisher Scientific has scrapped its previously planned $11.5 billion acquisition of Qiagen after its offer to buy…
Thermo Fisher to acquire Qiagen to expand specialty diagnostics portfolio
Thermo Fisher acquisition of Qiagen : US life sciences company Thermo Fisher Scientific has agreed to acquire Qiagen,…
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection
Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus…